ArticleScientific reports2026
Navigation activities in an organized colorectal cancer screening program improve follow-up colonoscopy completion.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Patient navigation is a promising intervention that could improve follow-up of abnormal fecal immunochemical test (FIT) results in colorectal cancer (CRC) screening. We describe changes in navigation activities in an organized screening program aimed to improve follow-up colonoscopy completion. Between 2022 and 2023, we decreased the time between an abnormal FIT result and contact from the program’s patient navigator from 3 months to 1 month and provided the patient navigator with direct access to schedule colonoscopies at two endoscopy sites. We conducted a pre-post analysis that examined the proportion of patients with abnormal FIT results who completed a colonoscopy, were referred for a colonoscopy, time to referral, time to colonoscopy, and colonoscopy outcomes including CRC diagnoses. Our analysis included 368 patients with abnormal FIT results: 175 in 2022 and 193 in 2023. After changes to navigation activities, colonoscopy completion within 1 year increased by 22.9% points (42.9% to 65.8%; p < 0.001). In 2022, the median time (interquartile range; IQR) to colonoscopy was 103.5 (IQR 60.2-161.5) days. In 2023, the median time to colonoscopy was 99.0 (IQR 52.0-150.0) days. Differences in the proportion of patients referred to colonoscopy, time to referral, and time to colonoscopy were not statistically significant. Patient navigation beginning within 1 month of an abnormal FIT result and granting a patient navigator direct access to the endoscopy scheduling template increased 1-year colonoscopy completion. Understanding navigation activities in CRC screening programs could inform broader adoption of practices that are associated with increased follow-up colonoscopy completion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.